46. 悪性関節リウマチ Malignant rheumatoid arthritis Clinical trials / Disease details


臨床試験数 : 4,356 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228

  
4 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2004-002157-30-SK
(EUCTR)
27/12/200410/11/2004A Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study to Evaluate the Safety and Efficacy of Oral TAK-715 in the Treatment of the Signs and Symptoms of Rheumatoid ArthritisA Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study to Evaluate the Safety and Efficacy of Oral TAK-715 in the Treatment of the Signs and Symptoms of Rheumatoid Arthritis Rheumatoid ArthritisProduct Code: TAK-715
Product Code: TAK-715
Takeda Europe R&D Centre Ltd. (TEuR&D)NULLNot RecruitingFemale: yes
Male: yes
400Phase 2Slovakia;Finland;Denmark
2EUCTR2004-002157-30-DK
(EUCTR)
07/12/200405/11/2004A Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study to Evaluate the Safety and Efficacy of Oral TAK-715 in the Treatment of the Signs and Symptoms of Rheumatoid ArthritisA Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study to Evaluate the Safety and Efficacy of Oral TAK-715 in the Treatment of the Signs and Symptoms of Rheumatoid Arthritis Rheumatoid ArthritisProduct Code: TAK-715
Product Code: TAK-715
Takeda Europe R&D Centre Ltd. (TEuR&D)NULLNot RecruitingFemale: yes
Male: yes
400Finland;Denmark
3EUCTR2004-002157-30-FI
(EUCTR)
01/12/200422/10/2004A Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study to Evaluate the Safety and Efficacy of Oral TAK-715 in the Treatment of the Signs and Symptoms of Rheumatoid ArthritisA Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study to Evaluate the Safety and Efficacy of Oral TAK-715 in the Treatment of the Signs and Symptoms of Rheumatoid Arthritis Rheumatoid ArthritisProduct Code: TAK-715
Product Code: TAK-715
Takeda Europe R&D Centre Ltd. (TEuR&D)NULLNot RecruitingFemale: yes
Male: yes
400Finland;Denmark
4NCT00760864
(ClinicalTrials.gov)
August 200424/9/2008Safety and Efficacy of TAK-715 in Subjects With Rheumatoid ArthritisA Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Efficacy of Oral TAK-715 in the Treatment of the Signs and Symptoms of Rheumatoid ArthritisArthritis, RheumatoidDrug: TAK-715 and methotrexate;Drug: MethotrexateTakedaNULLCompleted18 YearsN/ABoth432Phase 2NULL